Tag: biosimilars vs generics
Biosimilars are billed differently than generics under Medicare Part B. Each has its own HCPCS code and payment rate based on its ASP plus 6% of the reference product’s price. This system encourages biosimilar entry but doesn’t strongly incentivize switching. Learn how billing works and why adoption remains low in the U.S.
Medications
Archives
Recent-posts
OTC Cold Medications and Warfarin: What You Must Avoid to Stay Safe
Mar, 12 2026
Pentosan Polysulfate: Emerging Role in Joint Disorder Therapy
Oct, 18 2025
Isotretinoin for Severe Acne: Safety, Lab Tests, and Results
Apr, 20 2026
Radiation Side Effects: Skin Care, Fatigue, and Recovery Tips
Nov, 17 2025
How to Buy Cheap Generic Celexa Online Safely
Sep, 25 2025